New Insights on Diet and Exercise Impacting Prostate Cancer Outcomes Revealed at PCF Scientific Retreat
The 31st Annual PCF Scientific Retreat highlighted significant advancements in understanding how diet and exercise can influence prostate cancer outcomes. Key findings suggest that a plant-based diet and regular physical activity can improve survivorship and reduce mortality rates. Ongoing clinical trials, such as INTERVAL-GAP4 and Prostate-8-II, aim to further explore these interventions' effects on patients with prostate cancer.
At the 31st Annual PCF Scientific Retreat, Dr. Stacey Kenfield from UCSF presented compelling evidence on the relationship between physical activity and prostate cancer outcomes. Studies indicate that moderate levels of physical activity, such as 30 minutes of walking most days per week, are associated with reduced overall mortality. Higher levels of vigorous activity, like jogging for 30 minutes to an hour daily, correlate with decreased prostate cancer-specific mortality. These findings have influenced the Physical Activity Guidelines for Americans, now recommending at least 150 minutes of moderate or 75 minutes of vigorous aerobic activity weekly for prostate cancer survivors.
Research presented at the retreat also shed light on the impact of dietary patterns on prostate cancer outcomes. The Western dietary pattern, characterized by high intake of red and processed meats, is linked to increased mortality. In contrast, the Prudent and Mediterranean diets, emphasizing plant-based foods, fish, and healthy fats, are associated with lower overall mortality. A plant-based diet, in particular, shows promise in reducing the risk of prostate cancer progression, especially among patients with intermediate to high-risk cancer.
Ongoing clinical trials are further investigating the benefits of diet and exercise for prostate cancer patients. The INTERVAL-GAP4 study at UCSF is examining whether supervised exercise can improve overall survival in metastatic prostate cancer patients, with results expected in 1-2 years. Additionally, the Prostate-8-II study is exploring the effects of a digital health behavioral intervention on clinical outcomes.
Dr. David Nanus from Weill Cornell Medicine provided updates on a clinical trial evaluating a whole-food plant-based diet's impact on overweight and obese prostate cancer patients undergoing androgen deprivation therapy (ADT). Preliminary results from 46 enrolled patients show significant weight loss and improvements in body mass index (BMI) and fat mass among those on the plant-based diet, with effects persisting at six months. This trial underscores the potential of dietary interventions to mitigate ADT's metabolic side effects and improve patient health outcomes.
The findings presented at the PCF Scientific Retreat underscore the importance of lifestyle modifications in managing prostate cancer. Regular physical activity and a diet rich in plant-based foods can significantly impact survivorship and quality of life for patients. As research continues, these interventions offer hope for more effective, holistic approaches to prostate cancer treatment and care.

Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Related Topics
Reference News
[1]
Highlights of the 31st Annual PCF Scientific Retreat | Prostate Cancer Foundation
pcf.org · Jan 21, 2025
The PCF Annual Scientific Retreat highlighted advancements in prostate cancer research, emphasizing the role of exercise...